Cartesian Therapeutics
RNAC
#6732
Rank
$0.47 B
Marketcap
$19.80
Share price
3.61%
Change (1 day)
-40.00%
Change (1 year)

Revenue for Cartesian Therapeutics (RNAC)

Revenue in 2024 (TTM): $54.1 Million USD

According to Cartesian Therapeutics's latest financial reports the company's current revenue (TTM ) is $54.1 Million USD. In 2023 the company made a revenue of $26 Million USD a decrease over the revenue in the year 2022 that were of $0.11 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cartesian Therapeutics from 2015 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) $54.1 M108.05%
2023 $26 M-76.53%
2022 $0.11 B30.21%
2021 $85.07 M412.6%
2020 $16.59 M148.57%
2019 $6.67 M639.42%
2018 $0.9 M336.23%
2017 $0.2 M-97.44%
2016 $8.08 M34.47%
2015 $6.01 M